Crysandt M - Search Results

1

Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.

Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C, Reinhardt HC, Aguiar E, Schäfer-Eckart K, Burgues JMB, Steffen B, Bernal T, Krause SW, Riaza R, Schliemann C, Cervera J, Kaufmann M, Torres-Miñana L, Hänel M, Acuña-Cruz E, Jost E, Algarra JL, Crysandt M, Fransecky L, Cornago-Navascues J, Kraus S, Martinez-Lopez J, Einsele H, Niemann D, Neubauer A, Seggewiß-Bernhardt R, Scholl S, Klein SA, Schmid C, Schaich M, Schmidt-Hieber M, Zukunft S, Ho AD, Platzbecker U, Baldus CD, Müller-Tidow C, Thiede C, Bornhäuser M, Serve H, Levis M, Montesinos P, Röllig C, Schlenk RF. Kayser S, et al. Among authors: crysandt m. Haematologica. 2023 Jan 1;108(1):34-41. doi: 10.3324/haematol.2022.281137. Haematologica. 2023. PMID: 35678031 Free PMC article.

2

Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic response.

Crysandt M, Neumann B, Das M, Engelbertz V, Bendel M, Galm O, Osieka R, Jost E. Crysandt M, et al. Eur J Haematol. 2007 Dec;79(6):546-9. doi: 10.1111/j.1600-0609.2007.00955.x. Epub 2007 Sep 27. Eur J Haematol. 2007. PMID: 17903214

3

Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer.

Wilop S, Crysandt M, Bendel M, Mahnken AH, Osieka R, Jost E. Wilop S, et al. Among authors: crysandt m. Onkologie. 2008 Dec;31(12):665-70. doi: 10.1159/000165054. Epub 2008 Nov 14. Onkologie. 2008. PMID: 19060504

4

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy.

Wilop S, von Hobe S, Crysandt M, Esser A, Osieka R, Jost E. Wilop S, et al. Among authors: crysandt m. J Cancer Res Clin Oncol. 2009 Oct;135(10):1429-35. doi: 10.1007/s00432-009-0587-3. Epub 2009 Apr 28. J Cancer Res Clin Oncol. 2009. PMID: 19399518

5

Antineoplastic chemotherapy in cancer patients with methicillin-resistant Staphylococcus aureus (MRSA).

Crysandt M, Lemmen SW, Jost E, Brummendorf TH, Osieka R, Wilop S. Crysandt M, et al. Onkologie. 2010;33(11):598-603. doi: 10.1159/000321141. Epub 2010 Oct 19. Onkologie. 2010. PMID: 20975306

6

A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia.

Crysandt M, Kramer M, Ehninger G, Bornhäuser M, Berdel WE, Serve H, Röllig C, Kaifie A, Jost E, Brummendorf TH, Wilop S. Crysandt M, et al. Eur J Haematol. 2016 Jul;97(1):17-24. doi: 10.1111/ejh.12675. Epub 2015 Sep 17. Eur J Haematol. 2016. PMID: 26277604

7

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification.

Wilop S, Chou WC, Jost E, Crysandt M, Panse J, Chuang MK, Brümmendorf TH, Wagner W, Tien HF, Kharabi Masouleh B. Wilop S, et al. Among authors: crysandt m. J Hematol Oncol. 2016 Sep 1;9(1):78. doi: 10.1186/s13045-016-0308-8. J Hematol Oncol. 2016. PMID: 27585840 Free PMC article.

8

Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia.

Ventura Ferreira MS, Crysandt M, Ziegler P, Hummel S, Wilop S, Kirschner M, Schemionek M, Jost E, Wagner W, Brümmendorf TH, Beier F. Ventura Ferreira MS, et al. Among authors: crysandt m. Ann Hematol. 2017 Sep;96(9):1457-1461. doi: 10.1007/s00277-017-3049-z. Epub 2017 Jul 3. Ann Hematol. 2017. PMID: 28674830

9

Germ line predisposition to myeloid malignancies appearing in adulthood.

Crysandt M, Brings K, Beier F, Thiede C, Brümmendorf TH, Jost E. Crysandt M, et al. Expert Rev Hematol. 2018 Aug;11(8):625-636. doi: 10.1080/17474086.2018.1494566. Epub 2018 Jul 23. Expert Rev Hematol. 2018. PMID: 29958021 Review.

10

Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted region.

Naarmann-de Vries IS, Sackmann Y, Klein F, Ostareck-Lederer A, Ostareck DH, Jost E, Ehninger G, Brümmendorf TH, Marx G, Röllig C, Thiede C, Crysandt M. Naarmann-de Vries IS, et al. Among authors: crysandt m. Leuk Res. 2019 Jan;76:15-23. doi: 10.1016/j.leukres.2018.11.007. Epub 2018 Nov 17. Leuk Res. 2019. PMID: 30476680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page